Physician profile
Pejman Rohani
NPI 1619134475
$5,385.19
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,732 · 2020: $3,181 · 2021: $180 · 2022: $25.55 · 2023: $242 · 2024: $24.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,908.11 | 2019-2022 | |
| Penumbra, INC. | $206.18 | 2023 | Indigo System |
| Smith+Nephew, INC. | $73.79 | 2019-2020 | |
| Philips North America LLC | $36.13 | 2023 | |
| Misonix INC | $26.76 | 2020-2021 | |
| Boston Scientific Corporation | $24.44 | 2024 | Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $20.14 | 2019 | |
| W. L. Gore & Associates, INC. | $18.13 | 2019 | |
| Kci USA, INC. | $17.74 | 2021 | |
| Tactile Systems Technology INC | $17.03 | 2019 | |
| Medtronic Vascular, INC. | $13.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.66 | 2021 | |
| Cardinal Health 200 LLC | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pejman Rohani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.